BioCentury

12:59 AM GMT, Oct 26, 2012
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Top Story

FDA discloses concerns on Novo insulins

FDA is concerned about the cardiovascular safety of two Novo Nordisk A/S (CSE:NVO; NYSE:NVO) insulin products under review for Type I and

Read the full 222 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.